Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,041.28
(
0.26%
)
US TECH 100
25,608.00
(
0.44%
)
Dow Jones
48,578.72
(
0.24%
)
Brent Oil
94.73
(
-0.30%
)
Bitcoin
74,970.38
(
-0.28%
)
News Focus
News Focus
Post# of 821648
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

attilathehunt

Send PM Follow Ignore
Followers 70
Posts 8978
Boards Moderated 0
Alias Born 03/06/2016

attilathehunt

Re: Galzus Research post# 763995

Friday, 04/25/2025 7:58:39 PM

Friday, April 25, 2025 7:58:39 PM

Post# of 821648

is requiring another confirmatory trial



Seems to me, with all the data and the safety profile of DCVax-L doing a confirmatory is a death sentence to those it may benefit.

Why not do something similar to a P4 trial? Conditional approval with future data requirements. This would be a win-win for all!!

It's safe, so no issue of harming anyone and the potential to prolonging the lives of many!

Simple enough.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News